Breaking News Instant updates and real-time market news.

LGND

Ligand

$226.33

1.33 (0.59%)

09:30
08/07/18
08/07
09:30
08/07/18
09:30

Ligand price target raised to $260 from $230 at Craig-Hallum

Craig-Hallum analyst Matt Hewitt raised his price target for Ligand to $260 from $230 as the company continues to prove out the power of its unique business model. The analyst reiterates a Buy rating on the shares.

  • 06

    Nov

LGND Ligand
$226.33

1.33 (0.59%)

06/21/18
ARGS
06/21/18
INITIATION
Target $260
ARGS
Buy
Ligand initiated with a Buy at Argus
Argus analyst Mike Jaffe initiated Ligand Pharmaceuticals with a Buy rating and a price target of $260, saying the company is on track to generate solid earnings growth over the next several years thanks to its primary products - Promacta with use in blood clotting and Kyprolis for treatment of multiple myeloma. Jaffe adds that the company also has a "strong pipeline", with over half of its 165 programs under license currently in the clinical development or later stage. The analyst is also positive on Ligand's valuation at a PEG ratio of 1.2-times, which is "well below" the peer biotech industry average of 1.8-times.
06/27/18
CHLM
06/27/18
NO CHANGE
Target $230
CHLM
Buy
Ligand price target raised to $230 from $200 at Craig-Hallum
Craig-Hallum analyst Matt Hewitt raised his price target for Ligand to $230 from $200 following the company's announcement that WuXi Biologics has amended its license agreement for the OmniAb platform and has made a cash payment of $47M to Ligand. The analyst continues to believe that Ligand is a unique asset geared to provide investors with excellent earnings growth over the next several years as it layers in additional commercial assets from its extensive partnered pipeline. He reiterates a Buy rating on the shares.
06/28/18
HCWC
06/28/18
NO CHANGE
Target $239
HCWC
Buy
Ligand price target raised to $239 from $182 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals to $239 after the company amended its OmniAb agreement with WuXi Biologics and received a $47M payment. With its "coffers overflowing" with cash, the analyst expects Ligand's "strategic shopping should ramp up even more." Further, the company could also be highly selective in bringing additional internal pipeline assets forward, such as CE-Iohexol, expected to enter the clinic late 2018, Pantginis tells investors in a research note. He maintains a Buy rating on Ligand.
07/18/18
HCWC
07/18/18
NO CHANGE
Target $245
HCWC
Buy
Ligand target raised to $245 on better Promacta sales at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals (LGND) to $245 from $239 after its partner Novartis (NVS) this morning announced Q2 Promacta revenue of $292M, above his estimate of $258M. The analyst expects Promacta to achieve blockbuster status in 2018. He keeps a Buy rating on Ligand.

TODAY'S FREE FLY STORIES

ARZGY

Generali

$0.00

(0.00%)

19:22
06/19/19
06/19
19:22
06/19/19
19:22
Downgrade
Generali rating change at JPMorgan »

Generali downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GO

Grocery Outlet

$0.00

(0.00%)

19:00
06/19/19
06/19
19:00
06/19/19
19:00
Syndicate
Grocery Outlet 17.19M share IPO priced at $22.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

WIX

Wix.com

$145.83

1.19 (0.82%)

18:57
06/19/19
06/19
18:57
06/19/19
18:57
Hot Stocks
Wix.com CEO: Q1 was very good for us »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$9.17

0.13 (1.44%)

, ORCL

Oracle

$52.69

-0.19 (-0.36%)

18:44
06/19/19
06/19
18:44
06/19/19
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

AOBC

American Outdoor Brands

$9.17

0.13 (1.44%)

ORCL

Oracle

$52.69

-0.19 (-0.36%)

JSYN

Jensyn Acquisition

$5.00

-5.02 (-50.10%)

ABEO

Abeona Therapeutics

$4.90

-0.09 (-1.80%)

PIR

Pier 1 Imports

$0.67

-0.0059 (-0.87%)

SCS

Steelcase

$17.80

0.235 (1.34%)

LAND

Gladstone Land

$12.29

0.39 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 24

    Jun

  • 26

    Jun

  • 26

    Jun

  • 10

    Jul

  • 20

    Jun

TMUS

T-Mobile

$78.28

1.79 (2.34%)

, S

Sprint

$7.46

0.24 (3.32%)

18:39
06/19/19
06/19
18:39
06/19/19
18:39
Periodicals
T-Mobile readies for Boost auction if Dish talks fall through, Reuters says »

T-Mobile (TMUS) is…

TMUS

T-Mobile

$78.28

1.79 (2.34%)

S

Sprint

$7.46

0.24 (3.32%)

DISH

Dish

$38.90

-0.18 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBRA

Zebra Technologies

$200.57

-1.1 (-0.55%)

18:39
06/19/19
06/19
18:39
06/19/19
18:39
Hot Stocks
Zebra Technologies Chief of Product sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBRA

Zebra Technologies

$200.57

-1.1 (-0.55%)

18:23
06/19/19
06/19
18:23
06/19/19
18:23
Hot Stocks
Zebra Technologies CEO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$250.25

4.6 (1.87%)

, DVA

DaVita

$51.27

1.51 (3.03%)

18:13
06/19/19
06/19
18:13
06/19/19
18:13
Hot Stocks
FTC approves UnitedHealth's acquisition of DaVita Medical with conditions »

Healthcare provider and…

UNH

UnitedHealth

$250.25

4.6 (1.87%)

DVA

DaVita

$51.27

1.51 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SRRK

Scholar Rock

$17.11

-2.835 (-14.21%)

18:11
06/19/19
06/19
18:11
06/19/19
18:11
Syndicate
Scholar Rock 3M share Secondary priced at $15.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

QDEL

Quidel

$58.80

1.7 (2.98%)

18:01
06/19/19
06/19
18:01
06/19/19
18:01
Hot Stocks
Quidel receives 510k clearance for Triage TOX Drug Screen »

Quidel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$53.39

1.88 (3.65%)

, HPQ

HP Inc.

$20.63

0.1 (0.49%)

17:59
06/19/19
06/19
17:59
06/19/19
17:59
Periodicals
Dell, HP, Intel, Microsoft express opposition to Trump tariffs, Bloomberg says »

Dell Technologies (DELL),…

DELL

Dell Technologies

$53.39

1.88 (3.65%)

HPQ

HP Inc.

$20.63

0.1 (0.49%)

INTC

Intel

$47.08

-0.29 (-0.61%)

MSFT

Microsoft

$135.63

0.43 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 23

    Jun

  • 28

    Jun

  • 01

    Jul

  • 02

    Jul

  • 03

    Jul

  • 04

    Jul

  • 09

    Jul

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 06

    Aug

ORCL

Oracle

$52.69

-0.19 (-0.36%)

17:54
06/19/19
06/19
17:54
06/19/19
17:54
Hot Stocks
Oracle says 20% of Autonomous Database customers new to company »

Says plans to launch free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CB

Chubb

$149.48

1.37 (0.92%)

17:54
06/19/19
06/19
17:54
06/19/19
17:54
Hot Stocks
Chubb CEO sells 215.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

CABO

Cable One

$1,166.79

15.59 (1.35%)

17:52
06/19/19
06/19
17:52
06/19/19
17:52
Hot Stocks
Cable One COO sells 535 shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$0.00

(0.00%)

17:50
06/19/19
06/19
17:50
06/19/19
17:50
Syndicate
Slack Technologies stock reference point set at $26 per share »

Slack Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AABA

Altaba

$68.40

-0.24 (-0.35%)

17:37
06/19/19
06/19
17:37
06/19/19
17:37
Hot Stocks
Farallon Capital takes 5.0% passive stake in Altaba »

Farallon Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MSFT

Microsoft

$135.63

0.43 (0.32%)

17:36
06/19/19
06/19
17:36
06/19/19
17:36
Hot Stocks
Microsoft's online gaming service Xbox Live having issues with core services »

Xbox Live said, Xbox Live…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 23

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$293.02

0.69 (0.24%)

17:33
06/19/19
06/19
17:33
06/19/19
17:33
Periodicals
Mexico votes to ratify trade deal with U.S., Canada, WSJ reports »

Mexico's Senate has…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$293.02

0.69 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GVA

Granite Construction

$44.83

0.19 (0.43%)

17:31
06/19/19
06/19
17:31
06/19/19
17:31
Hot Stocks
Granite Construction awarded $39M dam project in Texas »

Granite announced that is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$42.78

0.695 (1.65%)

17:25
06/19/19
06/19
17:25
06/19/19
17:25
Hot Stocks
Canopy Growth shareholders approve resolutions regarding Acreage acquisition »

Canopy Growth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 21

    Jun

VTR

Ventas

$69.65

1.05 (1.53%)

17:21
06/19/19
06/19
17:21
06/19/19
17:21
Recommendations
Ventas analyst commentary at MUFG »

Ventas price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$187.41

-1.05 (-0.56%)

17:20
06/19/19
06/19
17:20
06/19/19
17:20
Periodicals
Facebook's crypto plans to face U.S. Senate scrutiny, Reuters reports »

According to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 10

    Jul

ORCL

Oracle

$52.69

-0.19 (-0.36%)

17:14
06/19/19
06/19
17:14
06/19/19
17:14
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle sees 1% revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

ORCL

Oracle

$52.69

-0.19 (-0.36%)

17:13
06/19/19
06/19
17:13
06/19/19
17:13
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle sees FY20 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

ORCL

Oracle

$52.69

-0.19 (-0.36%)

17:12
06/19/19
06/19
17:12
06/19/19
17:12
Earnings
Oracle sees Q1 adjusted EPS 80c-82c, consensus 80c »

Sees Q1 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.